Integer (NYSE:ITGR) Given New $147.00 Price Target at Truist Financial

Integer (NYSE:ITGR) had its price target reduced by Truist Financial from $150.00 to $147.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

Several other research analysts also recently issued reports on the stock. Oppenheimer initiated coverage on shares of Integer in a research note on Tuesday, July 16th. They issued an “outperform” rating and a $135.00 target price on the stock. KeyCorp increased their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Bank of America boosted their price target on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, October 1st. Citigroup increased their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Finally, Benchmark lifted their target price on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, October 21st. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $139.75.

Integer Trading Down 0.8 %

Integer stock traded down $0.99 during mid-day trading on Friday, hitting $125.77. The company’s stock had a trading volume of 187,373 shares, compared to its average volume of 312,382. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The business has a 50 day moving average price of $127.58 and a 200-day moving average price of $120.98. The stock has a market cap of $4.21 billion, a price-to-earnings ratio of 43.54, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. Integer has a 12 month low of $73.40 and a 12 month high of $133.53.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same period in the previous year, the firm earned $1.27 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, analysts forecast that Integer will post 5.3 EPS for the current year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the sale, the director now directly owns 2,280 shares of the company’s stock, valued at $272,824.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Integer

Hedge funds and other institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP acquired a new stake in Integer during the 1st quarter worth $786,000. Blue Trust Inc. lifted its stake in Integer by 460.4% in the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock worth $658,000 after purchasing an additional 4,636 shares in the last quarter. UniSuper Management Pty Ltd acquired a new position in shares of Integer during the 1st quarter worth approximately $976,000. Moloney Securities Asset Management LLC purchased a new stake in shares of Integer in the first quarter valued at approximately $927,000. Finally, Earnest Partners LLC lifted its position in Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after buying an additional 37,340 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.